Literature DB >> 17142452

The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant.

Young-Jae Nam1, Kartik Mani, Lily Wu, Chang-Fu Peng, John W Calvert, Roger S-Y Foo, Barath Krishnamurthy, Wenfeng Miao, Anthony W Ashton, David J Lefer, Richard N Kitsis.   

Abstract

Efficient induction of apoptosis requires not only the activation of death-promoting proteins but also the inactivation of inhibitors of cell death. ARC (apoptosis repressor with caspase recruitment domain) is an endogenous inhibitor of apoptosis that antagonizes both central apoptosis pathways. Despite its potent inhibition of cell death, cells that express abundant ARC eventually succumb. A possible explanation is that ARC protein levels decrease dramatically in response to death stimuli. The mechanisms that mediate decreases in ARC protein levels during apoptosis and whether these decreases initiate the subsequent cell death are not known. Here we show that endogenous ARC protein levels decrease in response to death stimuli in a variety of cell contexts as well as in a model of myocardial ischemia-reperfusion in intact mice. Decreases in ARC protein levels are not explained by alterations in the abundance of ARC transcripts. Rather, pulse-chase experiments show that decreases in steady state ARC protein levels during apoptosis result from marked destabilization of ARC protein. ARC protein destabilization, in turn, is mediated by the ubiquitin-proteasomal pathway, as mutation of ARC ubiquitin acceptor residues stabilizes ARC protein and preserves its steady state levels during apoptosis. In addition, this degradation-resistant ARC mutant exhibits improved cytoprotection. We conclude that decreases in ARC protein levels in response to death stimuli are mediated by increased ARC protein degradation via the ubiquitin-proteasomal pathway. Moreover, these data demonstrate that decreases in ARC protein levels are a trigger, and not merely a consequence, of the ensuing cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142452     DOI: 10.1074/jbc.M609186200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC.

Authors:  Yu-Zhen Li; Dao-Yuan Lu; Wei-Qi Tan; Jian-Xun Wang; Pei-Feng Li
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

Review 2.  Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage.

Authors:  Kartik Mani
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

Review 3.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

Review 4.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

5.  A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis.

Authors:  G Kung; P Dai; L Deng; R N Kitsis
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

6.  Induction of the apoptosis inhibitor ARC by Ras in human cancers.

Authors:  Lily Wu; Young-Jae Nam; Gloria Kung; Michael T Crow; Richard N Kitsis
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

7.  Mechanisms and management of doxorubicin cardiotoxicity.

Authors:  Y Shi; M Moon; S Dawood; B McManus; P P Liu
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

8.  Transcription factor Foxo3a prevents apoptosis by regulating calcium through the apoptosis repressor with caspase recruitment domain.

Authors:  Daoyuan Lu; Jinping Liu; Jianqin Jiao; Bo Long; Qian Li; Weiqi Tan; Peifeng Li
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 10.  Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.

Authors:  Mark J Ranek; Xuejun Wang
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.